Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
International Journal of Molecular Sciences
|
January 9, 2021
Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue
Subrata Deb, Mei Yieng Chin, Steven Pham, et al.
Cancers
|
August 7, 2021
Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy
Victor M Matias-Barrios, Mariia Radaeva, Chia-Hao Ho, et al.
Journal of Medicinal Chemistry
|
July 26, 2014
Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor
Huifang Li, Fuqiang Ban, Kush Dalal, et al.
Journal of Medicinal Chemistry
|
January 25, 2017
Correction to Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
Huifang Li, Fuqiang Ban, Kush Dalal, et al.
Radiation Research
|
December 31, 2004
Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages
Kirsten Skov, Hans Adomat, Mary Bowden, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 10, 2014
Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitro
Steven Pham, Subrata Deb, Dong Sheng Ming, et al.
Journal of Inflammation Research
|
December 2, 2020
Clusterin Deficiency Predisposes C57BL/6j Mice to Cationic Bovine Serum Albumin-Induced Glomerular Inflammation
Pengcheng Sun, Shijian Feng, Qiunong Guan, et al.
Urolithiasis
|
December 12, 2024
A mouse model for the study of diet-induced changes in intestinal microbiome composition on renal calcium oxalate crystal formation
Sarah Hanstock, Demian Ferreira, Hans Adomat, et al.
Cancer Chemotherapy and Pharmacology
|
March 21, 2009
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy
Alain G Musende, Andy Eberding, Catherine Wood, et al.
The Prostate
|
October 14, 2014
Capsaicin: a novel radio-sensitizing agent for prostate cancer
Natalie A Venier, Alexandra J Colquhoun, Hiroshi Sasaki, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
International Journal of Molecular Sciences
|
January 9, 2021
Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue
Subrata Deb, Mei Yieng Chin, Steven Pham, et al.
Cancers
|
August 7, 2021
Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy
Victor M Matias-Barrios, Mariia Radaeva, Chia-Hao Ho, et al.
Journal of Medicinal Chemistry
|
July 26, 2014
Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor
Huifang Li, Fuqiang Ban, Kush Dalal, et al.
Journal of Medicinal Chemistry
|
January 25, 2017
Correction to Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
Huifang Li, Fuqiang Ban, Kush Dalal, et al.
Radiation Research
|
December 31, 2004
Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages
Kirsten Skov, Hans Adomat, Mary Bowden, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 10, 2014
Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitro
Steven Pham, Subrata Deb, Dong Sheng Ming, et al.
Journal of Inflammation Research
|
December 2, 2020
Clusterin Deficiency Predisposes C57BL/6j Mice to Cationic Bovine Serum Albumin-Induced Glomerular Inflammation
Pengcheng Sun, Shijian Feng, Qiunong Guan, et al.
Urolithiasis
|
December 12, 2024
A mouse model for the study of diet-induced changes in intestinal microbiome composition on renal calcium oxalate crystal formation
Sarah Hanstock, Demian Ferreira, Hans Adomat, et al.
Cancer Chemotherapy and Pharmacology
|
March 21, 2009
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy
Alain G Musende, Andy Eberding, Catherine Wood, et al.
The Prostate
|
October 14, 2014
Capsaicin: a novel radio-sensitizing agent for prostate cancer
Natalie A Venier, Alexandra J Colquhoun, Hiroshi Sasaki, et al.
Page
of 7